Toronto - Free Realtime Quote CAD

Cronos Group Inc. (CRON.TO)

Compare
2.8000 -0.3000 (-9.68%)
As of 11:52 a.m. EST. Market Open.
Loading Chart for CRON.TO
DELL
  • Previous Close 3.1000
  • Open 2.9000
  • Bid 2.7900 x --
  • Ask 2.8000 x --
  • Day's Range 2.7900 - 2.9200
  • 52 Week Range 2.4800 - 4.2800
  • Volume 160,135
  • Avg. Volume 101,769
  • Market Cap (intraday) 1.07B
  • Beta (5Y Monthly) 1.02
  • PE Ratio (TTM) --
  • EPS (TTM) -0.2100
  • Earnings Date Nov 12, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 3.56

Cronos Group Inc. operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.

www.thecronosgroup.com

356

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Drug Manufacturers - Specialty & Generic

Industry

Recent News: CRON.TO

View More

Related Videos: CRON.TO

Performance Overview: CRON.TO

Trailing total returns as of 2024-11-06, which may include dividends or other distributions. Benchmark is

.

YTD Return

CRON.TO
1.08%
S&P/TSX Composite index
16.73%

1-Year Return

CRON.TO
10.24%
S&P/TSX Composite index
23.41%

3-Year Return

CRON.TO
57.83%
S&P/TSX Composite index
14.03%

5-Year Return

CRON.TO
74.24%
S&P/TSX Composite index
46.66%

Compare To: CRON.TO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CRON.TO

View More

Valuation Measures

As of 2024-11-05
  • Market Cap

    1.19B

  • Enterprise Value

    8.68M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    8.36

  • Price/Book (mrq)

    0.80

  • Enterprise Value/Revenue

    0.06

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -56.43%

  • Return on Assets (ttm)

    -3.73%

  • Return on Equity (ttm)

    -5.29%

  • Revenue (ttm)

    101.78M

  • Net Income Avi to Common (ttm)

    -57.37M

  • Diluted EPS (ttm)

    -0.2100

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    848.19M

  • Total Debt/Equity (mrq)

    0.19%

  • Levered Free Cash Flow (ttm)

    -30.52M

Research Analysis: CRON.TO

View More

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue 27.76M
Earnings -8.76M
Q3'23
Q4'23
Q1'24
Q2'24
-40M
-20M
0
20M
 

Analyst Price Targets

2.77
3.56 Average
2.8000 Current
5.00 High
 

People Also Watch